Hepato-Gastroenterology, cilt.58, ss.900-903, 2011 (SCI-Expanded)
Background/Aims: Anticoagulant therapy is an accepted treatment for Budd-Chiari syndrome (BCS). However, the natural course of untreated patients is unclear. We aimed to evaluate the efficacy of anticoagulant therapy on survival in BCS.